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ABSTRACT. 
 
Quaternary structures of amino acid tRNA ligases/synthetases (aaRS) in the native as well as 
in denatured forms were examined by molecular weight determinations (paper I-IV). 
Analytical ultracentrifugation, gel electrophoresis, gel chromatography were used in these 
investigations. The aaRSs were obtained from bacteria and yeast: LysRS and ValRS from S. 
cerevisiae, AspRS, LysRS and SerRS from E. coli, AsnRS, LysRS, SerRS and ValRS from 
Bacillus stearothermophilus. The quaternary structures of ValRSs from S. cerevisiae and B. 
stearothermophilus are both monomeric  (the -type), whereas all the other aaRSs are  
homodimers (the 2-type). Two of the aaRS-enzymes have also been crystallized. Both of 
them are LysRS and their structures were examined with X-ray crystallography. LysRS from 
S. cerevisiae with a resolution of 5 to 6 A in all directions, and from B. stearothermophilus 
LysRS with a resolution of 8 A.  
 
In Paper V  the enzyme HMG-CoA lyase was investigated. The activity of this enzyme is 
found in Rhodospirillum rubrum cells grown anaerobically in the light with leucine as the 
carbon source. A 1.2 kb long DNA segment from R. rubrum has been sequenced and includes 
the first identified gene for a putative 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase, 
termed hmgL, from a photosynthetic organism.   
 
A parallel project concerned the characterization of a DNA homeobox (HD), where it was 
shown that the T7 promoter sequence lacked an important guanine for the transcription of this 
gene.  
 
The analytical ultracentrifugation method as described in this thesis played an important role 
already when the first protein structures were characterized, and the interest has increased 
dramatically during the last ten years partly due to automation.  I hope that my early work 
on the application of analytical ultracentrifugation to tRNA ligases/synthetases  (aaRSs) also  
helped to inspire  these exciting  developments.  
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Svensk sammanfattning av innehållet i denna avhandling med 
titeln “Characterization of Amino Acid tRNA Ligases using the 
Analytical Ultracentrifuge”. 
 
I. Subunit Structure and Binding Properties of Three Amino Acid Transfer Ribonucleic Acid 
Ligases. 
 
Karakterisering av tre aminosyra tRNA ligaser: E
Lys
 från jäst och E. coli samt E
Val
 från jäst. 
 
Med analytisk ultracentrifug kunde dessa bestämmas med avseende på molvikter både nativt 
och denaturerat bestående av två identiska subenheter för E
Lys 
från jäst och E. coli men endast 
en enhet för E
Val
 från jäst. Vid samtliga bestämningar användes jämviktscentrifugering med 
avseende på sedimentation. 
 
Renheten hos dessa framställda enzymer kontrollerades med hastighetskörning för 
sedimentationen som påvisades med en så kallad Schlieren topp. Denna var helt symmetrisk 
utan bidrag från några fragment av dessa enzymer. 
 
 
II. Properties of the Sulfhydryl Groups of Three Amino Acid: Transfer RNA Ligases. 
 
Här kunde konstateras att de tidigare studerade aminosyra tRNA ligaserna från jäst 
och E.coli uppvisade konformationsförändring som var påvisbar med hjälp av CD 
vid våglängden 220 nm där de studerade liganderna saknade bidrag avseende α-
helix. 
 
Tre system användes för detta: 
 
1. Enzym med motsvarande aminosyra. 
 
2. Enzym med ATP, Mg2+ och aminosyra. 
 
3. Enzym med motsvarande tRNA och Mg2+ . 
 
Med avseende på α-helix innehåll hos dessa tre enzymer så visade sig system 2 ge 11 
% mer α-helix för  ELys från jäst och 26,6 % mer α-helix för EVal från jäst. 
 
System 3 visade mindre α-helix med 11 % för ELys från jäst och 8,3 %  för ELys från E.coli. 
 
Detta noterades inte i publikationen men finns med i avhandlingen. 
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III. Simultaneous Purification and Some Properties of Aspartate: tRNA Ligase and 
Seven Other Amino-acid: tRNA Ligases from Escherichia coli. 
 
På samma sätt  som vid publikation I studerades EAsp och ESer från E. coli. Med 
analytisk ultracentrifug och jämviktscentrifugering av sedimentationen kunde både nativt och 
denaturerat enzym ge upplysning om förekomst av subenheter. Det visade sig vara två 
identiska enheter i dessa båda enzym. Storleken av dessa bekräftades även med SDS-PAGE. 
 
Det nativa enzymets storlek kunde också erhållas med gelfiltrering. 
 
Renheten av provet innehållande enzymet kontrollerades dels med analytisk ultracentrifug 
och sedimentationshastighet som gav en symmetrisk Schlieren topp. Dels också med PAGE 
som ett enda band på gelen för E
Asp
. 
 
 
IV. Purification and Some Properties of Asparagine, Lysine, Serine, and  Valine: 
tRNA Ligases from Bacillus  stearothermophilus. 
 
Här användes en bakterie som är mycket värmestabil nämligen Bacillus  
stearothermophilus. 
 
Fyra aminosyra tRNA ligaser studerades såsom: EAsn, ELys, ESer och EVal. 
 
Resultatet av dessa studier med avseende på förekomst av subenheter gav följande: 
 
Tre av dessa enzymer såsom: EAsn, ELys och ESer hade två identiska subenheter men EVal 
bestod av en enhet som redovisas i avhandlingen men inte i publikationen. 
 
Värmestudier i temperatur intervallet 50 - 70° C visade att bindnings-ställen för ATP och 
aminosyra på enzymet påverkades mer än stället för bindandet av tRNA. Detta tyder på att det 
senare är mera beläget på utsidan av enzymet medan de andra binder i det inre av detta. 
 
 
V. A 3-Hydroxy-3-Methylglutaryl-CoA Lyase Gene In the Photosynthetic Bacterium 
Rhodospirillum rubrum. 
 
Ett enzym från en fotosyntetisk bakterie Rhodospirillum rubrum studerades. Först med DNA 
sekvensering av hmgL genen för detta enzym HMGL som erhölls från en plasmid pÅS6 som 
är genen hmgL insatt i vektorn pET3a. Enzymet erhölls efter transformation av denna plasmid 
i E. coli bakterie som användes för överuttryck genom induktion med IPTG. Diverse olika 
expressions-system användes och slutligen erhölls en ny plasmid pCYB1 / hmgL som 
transformerades in i E.coli. 
 
Det tidigare erhållna enzymet HMGL kontrollerades med avseende på enzymaktivitet med 
olika ”kolkällor” som substrat och NADH syntes som påvisades i spektrofotometer. Detta 
som bevis på att acetoacetat som är en så kallad ketonkropp bildats.    
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CONTRIBUTION REPORT 
 
Paper I, Paper II, Paper III, Paper IV. 
 
I performed all the Mr determinations for the different proteins with analytical 
ultracentrifugations under native conditions as well as under denatured conditions. The 
analytical methods were sedimentation velocity with Schlieren optics and sedimentation 
equilibrium with Interference optics. Moreover, I used gelfiltrations as well as SDS-PAGE for 
confirmation of the Mr results. I was not involved in the Appendix belonging to Paper I.  
 
 
Paper II 
 
I performed binding studies with different ligands for studies of conformational changes in 
the enzymes with Circular Dichroism in the Cary 60 spectropolarimeter as the analytical 
instrument.  
 
Paper V 
 
I performed manually the DNA sequencing of the gene for 3-hydroxy-3-methylglutaryl-CoA 
(HMG-CoA) lyase, termed hmgL (from R. rubrum), with an ALFexpress DNA sequencer. 
The plasmid with this hmgL in the vector pET3a was first transformed into E. coli 
BL21(DE3)pLysS and the hmgL was finally in the vector pCYB1 to be transformed into E. 
coli K12 for the production of HMG-CoA lyase (HMGL). I performed measurement of the 
enzyme HMGL activity to study the formation of acetyl-CoA and the ketone body 
acetoacetate from HMG-CoA. 
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ABBREVIATIONS. 
 
A  aminoacyl site (ribosome) 
aa  amino acid 
aa-AMP  aminoacyl adenylate 
aaRS  aminoacyl-tRNA synthetase (EC 6. 1. 1)  
  or amino acid tRNA ligase 
aa-tRNA  aminoacyl-tRNA 
AMP  adenosine monophosphate 
ATP  adenosine triphosphate 
BD  benzoylated DEAE 
CD  circular dichroism 
CPC  cetyl pyridinium chloride 
CTL  cytotoxic T lymphocyte cell 
DEAE  di-ethyl-amino-ethyl 
DHU  di-hydro-uridine (= UH2) 
DNA  deoxyribo-nucleic acid 
DTNB  5,5´-di-thiobis (2-nitro-benzoic acid) (= Nbs2) 
DTT  di-thio-threitol 
E  exit site (ribosome) 
EDTA  ethylene-diamine-tetra-acetate 
fMet  formyl methionine 
GDP  guanosine diphosphate 
GSH  glutathione 
GTP  guanosine triphosphate 
GuHCl  guanidine-HCl 
HD  homeodomain 
HG  3-hydroxyglutarate 
HMG-CoA  3-hydroxy-3-methylglutaryl-CoA 
hmgL  HMG-CoA lyase gene 
IF  initiation factor 
IPTG  Isopropyl β-D-1-thiogalactopyranoside  
Mr  molecular weight (reduced weight average) 
Mw  molecular weight 
mRNA  messenger ribonucleic acid 
NMR  nucleo magnetic resonance 
P  peptidyl site (ribosome) 
PAGE  poly-acrylamide gel-electrophoresis 
PCR                                    polymerase chain reaction 
Pi  phosphate (inorganic) 
PPi  pyrophosphate (inorganic) 
pI  isoelectric point 
PMSF  phenyl methyl sulfonyl fluoride 
RE  restriction enzyme 
RF  release factor 
RNA  ribonucleic acid 
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RNAP  RNA polymerase 
rpm                                    revolution per minute 
rRNA  ribosomal ribonucleic acid 
RS-  protein (enzyme) with thiol group 
SDS  sodium-dodecyl-sulfate 
tRNA  transfer ribonucleic acid 
tRNAaa  amino acid specific tRNA 
Tu  transfer (elongation) factor (unstable) (= EF-Tu) 
Ts  transfer (elongation) factor (stable) (= EF-Ts) 
T C   = pseudouridine 
 
 
KEYWORDS:  
amino acid tRNA ligase; analytical ultracentrifugation (AUC); antennapedia; Antp 
gene; binding site; circular dichroism; conformational change; HMG-CoA lyase; 
homeodomain; ketone bodies; molecular weight; pAop2CS ; quaternary structure; 
temperature inhibition; thiol group; tRNA; X-ray crystallography. 
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1. AIMS OF THIS THESIS 
 
The first four papers in this thesis (I-IV) aim at the characterization of structure and 
conformational changes of amino acid tRNA ligases, a class of enzymes that is still a focus of 
todays research (see Figs. 1 and 2). 
 
The goal of the studies of the enzyme HMGL was to receive the possibility to get a more 
human-like alternative for the production of reserve energy when this was needed for people 
from under–developed countries.  
 
The parallel project with characterization of the transcription factor AntpHD aimed at getting 
better knowledge for the development of different cells finally producing new organic parts in 
the whole body. 
 
Fig. 1. Published  Items in Each Year for “Amino Acid tRNA Ligases”. 
 
 
 
 
 
    Fig. 2. Citations in Each Year for “Amino Acid tRNA Ligases”. 
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2. INTRODUCTION 
 
2.1. Interactions between proteins and other molecules  
 
The immune response is mediated by the interaction of the immunoglobulin (antibody) 
protein with an antigen molecule. Metabolic processes are regulated by the binding of small 
molecules to enzymes. Muscle contraction is mediated by interaction of calcium ions with 
regulatory proteins that in turn interact with the contractile proteins to initiate contractile 
work. Understanding the nature of these interactions is central to understanding the chemical 
and physical processes that constitute life. Many main interests are in the application of 
physical methods to the study of dynamically reversible protein-protein interactions (PPI) and 
protein-nucleic acid interactions that are relevant to physiological function in normal and 
diseased states. Many interactions peculiar to disease states can be targets for drug therapy. 
These antibody molecules can be used as vehicles for the targeted delivery of therapeutic 
agents to kill breast cancer cells. The engineered antibody proteins are produced by using 
techniques of molecular biology to produce antibody molecules with the desired reactivity 
and properties. A very important step in designing protein molecules is the assessment of their 
properties in solution and their strength of binding to unique molecules found on the surface 
of breast cancer cells. The physical methods of analytical ultracentrifugation are being applied 
to the analysis of the strength of binding of the antibody molecules after changes are 
engineered into them. New highly sensitive techniques for the analytical ultracentrifuge have 
been developed and are being applied to these and other problems.  
 
 
2.2. Historical reflection 
 
The results from these examinations concerning molecular weights and quaternary structures 
of the proteins (Papers I – IV) were obtained by using the methods Sedimentation Velocity 
and Sedimentation Equilibrium. These analysis are still applied today with the current 
versions of the analytical ultracentrifuges. I had to do all optical corrections for the whole 
optical system with focusing of the many lenses involved in this (Fig. 3) before it was 
possible to begin with registration of analytical data for the proteins I examined and made 
calculations for from experimental results received from the work with the Spinco Model E 
analytical ultracentrifuge. The work was done between 1970 to 1980 when the use of this 
examination with Spinco Model E was very hard to handle without long-term experience 
before the results from experiments could be received with this instrument. Data was 
collected on film and manually interpreted. The structure of DNA and isolation of the polio 
virus are also linked to work on the Spinco
1
 Model E.  
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Fig.  3. Spinco Model E optical parts. 
 
   
 
2.3. DNA technologies 
 
 
After a break I returned to research at University of Gothenburg in the mid 1990
th
 but this 
time with slightly different objectives and the use of different technologies.  The emphasis 
was now on DNA  and the use of a wide variety of different techniques in gene technology 
The beginning of this research was concerned the enzyme HMGL which can produce ketone 
bodies essential for reserve energy. During starvation this missing of HMGL can be 
dangerous and is a deadly risk factor in certain under-developed areas in the world. The 
production and purification of this enzyme from bacteria was studied with the purpose of later 
use with humans (Paper V).  
 
The interest in cell differentiation for many different cell organisms from bacteria to plant and 
also human beings
2
 has been studied since long
3
 . The origin for this was already in late 
1980
th
 presented from the group of Walter Gehring
4
 in Basel Schwitzerland. The insect 
Dosophila melanogaster was used to receive the gene which resulted in  the so called 
homeodomain (HD) which could bind to DNA and in this way produce different cell 
organelles
5
,
6
,
7
,
8
. 
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When they made one mutant of this gene they got the result of Antennapedia (Fig. 4.) which 
means the change for legs instead of antennae
9
  in this insect. The short name Antp stands for 
this and another mutation when one amino acid cystein (C) in position 39 of the sequence was 
changed to serine (S) resulted in a monomer of this protein instead of the dimer. This was 
given the complete name Antp(C39S) for this homeodomain. 
 
 
 
  
 
Fig. 4. The mutation Antennapedia.  
 
Retrieved from:”http//en.wikipedia.org/w/index.php?title=Antennapedia&oldid=566572503 
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3. HISTORICAL REFLECTIONS ON THE BIRTH OF  
    MODERN BIOCHEMISTRY 
 
3.1. Background  
 
The living cell is the smallest part of all biological materia, such as plants and 
animals, which was first proposed by Schleiden and Schwann in 1839. The chemical 
basis of life in simple cells like bacteria and yeast is very much alike those in higher 
organisms. Cells in higher organisms can differentiate into cell types in different 
organs but they still keep their properties as single cells. This "vitalism" was for a 
long time thought to be some vital force outside the laws of chemistry. At first the 
most important group of macromolecules was believed to be the proteins because of 
the evidence that all enzymes are proteins. It was also found that the chromosomes 
contained proteins so the genes with high degree of specificity were thought to be 
proteins instead of the other chromosomal component, the nucleic acids. Nucleic 
acids were thought to be too small molecules in size and incapable of carrying 
sufficient genetic information which, as is now known, was wrong. 
 
The chemical behaviour of small molecules of importance in life science, like the 
amino acids and nucleotides was first understood. The larger molecules, like proteins 
and nucleic acids, were difficult to study because they were much less stable and lost 
their activity during isolation. Before it was possible to get the detailed structure of a 
protein much work was needed to establish that the protein was chemically pure and 
biologically active. This demanded techniques for isolation, to reveal homogeneity of 
the product and to provide data on molecular size. To answer these questions 
regarding the physical-chemical properties of macromolecules in solution, topics like 
osmotic properties and the movement of macromolecules under electrical and 
centrifugal forces were investigated. 
A striking contribution to the study of biological macromolecules was the 
development, in the 1920s, of centrifuges that rotated at high speed (ultracentrifuges) 
and that could cause rapid sedimentation of proteins and nucleic acids. 
Ultracentrifuges equipped with optical devices to observe exactly how fast the 
molecules sedimented were extremely valuable in obtaining data on the molecular 
weight of proteins and establishing the concept that proteins, like smaller biological 
molecules, are of discrete molecular weights and shapes. It was found that the sizes 
of proteins vary with molecular weights between 10,000 and 1,000,000.  
The composition of proteins was also studied by means of chromatography. Since 
Fischer's10 establishment that protein molecules are composed of amino acids linked 
by peptide bonds it was not until 1941 when Martin11 and Synge developed 
separation methods (partition chromatography) it became a routine matter to 
separate quantitatively the 20 amino acids found in proteins. Sanger12 used these 
methods to solve the primary structure of insulin, which was of great importance in 
the study of proteins to show that each type of protein has a specific composition and 
sequence of amino acids. 
Another very important technique used in understanding macromolecules was X-ray 
crystallography. With this technique it was possible to exactly identify the three-
20 
 
 
dimensional (3-D) arrangement of the atoms in molecules. Since the initial 
crystallization of inorganic molecules many important cell components have been 
crystallized which has resulted in resolved structures like the one of hemoglobin by 
Perutz13 and myoglobin by Kendrew14. In 1951 Pauling15 proposed a structure which 
he called the alpha-helix. It was a stereochemical arrangement of amino acids linked 
together by peptide bonds in helical configuration. This theory was also supported 
by Perutz's16 work with synthetic polypeptide chains. By means of heavy atoms 
attached to protein molecules it was possible in 1953 to obtain correct structures from 
X-ray diffraction data. In 1959 this method helped Perutz and Kendrew to solve the 
structures of hemoglobin 13 and myoglobin14 with their amino acid chains folded as 
-helices in some regions and very irregularly in others. Because of Pauling's -helix 
theory in 1951 it was possible to develop an elegant theory for the diffraction of 
helical molecules which finally helped Watson17 and Crick to solve the DNA 
structure, a complementary double helix, in 1953. How DNA controls the sequence of 
amino acids in proteins is summarized by the formula called the central dogma. 
Exception to the central dogma is certain RNA viruses (<     ). 
  СDNA                      RNA                   >         protein 
    Replication. 
                 Transcription.                                                    Translation. 
        
Avery18 and his co-workers reported in 1943 that the active genetic component was 
deoxyribonucleic acid (DNA). Now it is known that the chromosome with its genes 
are made of DNA in all prokaryotic and eukaryotic organisms. In viruses, genes 
consists either of DNA or of ribonucleic acid (RNA). In the cell the DNA double helix 
consists of two antiparallell and complementary polynucleotide strands. In the 
replication of DNA, the two strands of a double helix unwind and separate as new 
chains are synthesized. Each parent strand acts as a template for the formation of a 
new complementary strand Stryer19.  
The sugar unit in RNA is ribose whereas deoxyribose is found in DNA. Another 
difference is the base uracil (U) in RNA instead of thymine (T) in DNA. In RNA 
uracil form base pairs with adenine (A). Cytosine (C) is always paired with guanine 
(G). Cells contain three kinds of RNA: messenger RNA (mRNA), transfer RNA 
(tRNA), and ribosomal RNA (rRNA). All three types of RNA are synthesized 
according to instructions given by a DNA template. Transcription occurs at one of 
the unwinded DNA strands according to the sequence in different genes catalysed by 
RNA-polymerases. 
Recent results from studies of one nucleotide guanosine tetraphosphate abbreviated 
as ppGpp20 ("magic spot") concerning the role as control of the gene expression 
promoter - specifically by interacting with RNA polymerase (RNAP) without 
binding to DNA. Its mechanism of action with a binding site for ppGpp on E. coli 
RNAP has been identified by crosslinking, protease mapping, and analysis of mutant 
RNAPs that fail to respond to ppGpp. The binding site is at an interface of two 
RNAP subunits, ω and β´, and its position suggests an allosteric mechanism of action 
involving restriction of motion between two mobile RNAP modules. Identification of 
21 
 
the binding site allows prediction of bacterial species in which ppGpp exerts its 
effects by targeting RNAP. Genes responsible for ppGpp synthesis and degradation 
(the relA family) have been identified in almost all bacterial genomes examined, as 
well as in chloroplasts. The response to amino acid starvation referred to as the 
stringent response includes an extensive reprogramming of transcription. Binding of 
ppGpp to E. coli RNA polymerase in vitro and in vivo inhibits transcription from 
many promoters required for ribosome synthesis, activates transcription from a 
number of promoters for amino acid biosynthesis, and regulates a variety of 
additional promoters as well. Genome-wide approaches indicate that ppGpp 
regulates the levels of transcripts from several hundred genes involved in 
macromolecular biosynthesis pathways and a variety of stress responses, justifying 
the original name given to the modified nucleotide, "magic spot". 
The language of the nucleic acids (nucleotides) must in some way be translated to the 
language of the proteins (amino acids) when the genetic information is expressed to a 
protein molecule. According to the adaptor hypothesis, (at least) 20 different 
adaptors (now known as tRNA) are needed, one (or more) each for the 20 different 
amino acids, to bring the information from the base sequence in RNA (now known as 
mRNA) to the growing polypeptide chain (at the ribosome). The base sequence in 
mRNA is read in triplettes (codons) by the complementary base sequence in tRNA 
(anticodon). The tRNA has a free 3'-end of bases (-C-C-A) where the amino acid 
specific for that tRNA is fixed. 
Recent studies have begun to reveal the molecular mechanisms for quality control21 
concerning accuracy during the selection of aminoacyl-tRNAs on the ribosome and 
their base pairing with mRNA. The accuracy of tRNA selection is further enhanced 
in vivo by competition between ligases for their cognate tRNAs and in some cases by 
the recruitment of additional proteins that enhance binding. The principal reason 
that the inability to discriminate similar amino acids does not compomise the fidelity 
of translation is that the respective aminoacyl-tRNA ligases have proofreading 
activities. These activities have been found to operate at two levels: Most commonly, 
the activated noncognate aminoacyl-adenylate is hydrolyzed before transfer to tRNA 
can occur; less frequently, a noncognate aminoacyl-tRNA may be ligated that is then 
deacylated. The molecular mechanisms underlying these proofreading activities have 
recently been elucidated for isoleucyl-tRNA ligase. This enzyme contains two distinct 
catalytic sites that present a double sieve during substrate selection. The first sieve 
serves to exclude amino acids larger than isoleucine from the active site but is unable 
to exclude valine, and consequently valyl-AMP (adenosine monophosphate) is 
ligated.                                                                                                                                        
The second sieve then acts by hydrolyzing valyl-AMP  at a structurally distinct 
"editing" site. The proofreading activity of isoleucyl-tRNA ligase is dependent on 
specific sequences in cognate isoleucine tRNA species, which trigger the 
translocation of misactivated valine from the catalytic to the editing site, further 
enhancing the accuracy of isoleucyl-tRNA ligation by the enzyme. Isoleucyl-tRNA 
ligase provides a highly effective point of quality control, as seen from the 
observation that only about 1 in 3000 isoleucine codons are misread as valine during 
protein synthesis.    
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4. tRNA LIGASES AND AMINO ACID ACTIVATION 
 
4.1. Description of players in translation 
 
4.1.1. Over all reactions 
 
The covalent linking of an amino acid (aa) to its specific tRNA is made in two steps. 
First the amino acid is bound to adenylic acid (AMP) by cleavage of adenosine 
triphosphate (ATP) catalyzed by the enzyme aminoacyl-tRNA ligase (aaRS) specific 
for this amino acid. Mg2+ is needed in this reaction. 
 
aaRS + aa + ATP  (aa    AMP:aaRS) + PPi   1. 
 
In the second part of the process the amino acid specific tRNA reacts with the 
aminoacyl adenylate (aa    AMP) bound to the enzyme so the amino acid can bind to 
its tRNA. 
 
(aa    AMP:aaRS) + tRNAaa  aa    tRNAaa + AMP + aaRS  2. 
 
The sum of these two reactions is: 
  
               aaRS 
aa + ATP + tRNAaa  aa    tRNAaa + AMP + PPi  3. 
 
The high energy bond formed between the amino acid and its tRNA makes the 
amino acid activated so that this energy can be used in forming peptide bonds 
between amino acids at the ribosome. 
 
4.1.2. Transfer RNA 
 
The only way for the amino acid to find its right place in the growing polypeptide 
chain is through the recognition between the anticodon of tRNA and the codon of 
mRNA. Therefore the tRNA structure was at first believed to be a single 
polynucleotide chain with several unusual bases disrupting double-helical hairpin 
regions, thereby exposing free keto and amino groups. Depending upon the specific 
bases the free groups may form secondary bonds to mRNA, to a ribosome or to the 
aaRS needed to attach an amino acid to its specific tRNA molecule. The two-
dimensional structure of tRNA looks like a cloverleaf22 with three unpaired loops 
and one "extra arm". At the shaft of the cloverleaf is the free 3'-end (CCA) where the 
amino acid can be attached. Two of the loops are named T C- and DHU- loop (T- 
and D-loop), respectively, depending upon the names of the specific bases in these 
loops. The third loop between these is the one where the anticodon is situated which 
also gives the name of this loop. The "extra arm" is named variable loop. 
The 3-D shape of tRNA (Fig. 5) is, however, different from a cloverleaf (Fig. 6). It is L-
shaped with a coiled structure where the T- and D-loops are close together in the 
knee of the L-shape. This information has come from X-ray crystallography of yeast 
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phenylalanine tRNA23, 24. The importance of the different parts of the tRNA molecule 
in the recognition of its specific aaRS is discussed by Normanly25 and Abelson as 
tRNA identity. They stress the importance of certain base pairs and that the 
anticodon is a recognition element for the majority of tRNAs. Identity elements can 
be of two kinds. Positive elements in tRNAs for direct recognition by the cognate 
aaRS and negative elements in tRNAs that block the recognition. 
In tRNA the structure of the cluster of nucleotides formed by the interaction of the T-
loop and D-loop forms a patch that arches out from the surface of the molecule. The 
nucleotides in this patch are different between amino acid specific tRNA molecules. 
There can be insertions or deletions in the D-loop which can change the 
configuration of this "pocket". Klug26 suggested that this variable pocket may "form 
part of a recognition system for different tRNAs, perhaps for sorting into classes for 
synthetase discrimination". More recent results about tRNA identity (acceptor end, 
anticodon and variable pocket) and which parts in the tRNA structure that cause 
conformational changes in binding to aaRS is described by McClain27, 28. Several 
described experiments provide strong genetic and biochemical evidence that 
tRNAAla identity depends not only on direct recognition of G3-U70, but also on the 
helix deformability associated with this wobble pair and other local features. Other 
experiments support the proposal that both sequence and structure contribute to 
recognition of G3-U70 in tRNAAla. A general conclusion from studies of the tRNA-
aaRS interaction is that the specificity function can be supplied by different 
nucleotide combinations in similar positions in various tRNA molecules. This feature 
is illustrated by the importance of some or all of the first three base pairs in the 
acceptor end and residue 73 of many E. coli tRNAs. The data also indicate that 
identity determinants are present in one or more anticodon nucleotides of many 
tRNAs, and in the variable pocket of several tRNAs. 
Recently it has come information about tRNAs that they have not only this well-
known canonical role during protein biosynthesis but also to perform additional 
functions such as acting as signaling molecules in the regulation of numerous 
metabolic and cellular processes in both prokaryotes and eukaryotes. Aminoacylated 
tRNAs have also been implicated as substrates for non ribosomal peptide bond 
formation in the case of cell wall formation, protein labeling for degradation, 
modification of phospholipids in the cell membrane, and antibiotic biosynthesis29, 30, 
31. Another function for tRNAs is that they can act as an effective scavenger of 
cytochrome c, consistent with a role in regulating apoptosis. 
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Fig. 5. Frequency data superimposed on tRNA model. Circle diameter is proportional 
to frequency. Predicted by structural comparisons (A). Experimentally observed 
tRNA determinants (B). (Adapted from Mc Clain 27, 28). 
 
 
 
 
 
Fig. 6. Cloverleaf structures of yeast tRNAAsp (a) and E. coli tRNAGln (b). (Adapted 
from Cavarelli and Moras 64). 
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Fig. 7. Complexes tRNAGln - GlnRS (a) and tRNAAsp - AspRS (b). The Class I GlnRS 
binds tRNAGln from the minor groove side of the acceptor stem whereas Class II 
AspRS interacts  with the major groove of the tRNAAsp acceptor stem.  (Adapted 
from Cavarelli and Moras 64). 
 
 
 
 
 
 
 
 
 
 
Fig. 8. Schematic drawing of the Rossmann fold, as seen in Class I aaRSs (a), and the 
antiparallel  sheet that forms the catalytic domain of Class II aaRSs (b). (Adapted 
from Delarue and Moras 70). 
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4.1.3. Amino acid tRNA ligase 
 
The importance of the correct recognition32 between aaRS and tRNAaa  is mentioned 
in discussing tRNA. In trying to understand the mechanism of amino acid activation 
and acyl transfer to cognate tRNAs much work has been done to find out what parts 
of these two 3-D structures (Fig. 7) that are in contact with each other in the aaRS-
tRNAaa complex33. The aaRSs are divided into two structural classes: 
Class I enzymes are predominantly specific for larger hydrophobic amino acids; they 
acylate the 2'-hydroxyl group of the 3'-terminal adenosine ribose of the tRNA and 
their amino acid activation domains incorporate parallel -structures, and folds 
of the Rossmann34,35 type (Fig. 8).  
Class II enzymes are predominantly specific for smaller amino acids; they acylate the 
3'-hydroxyl group of the terminal ribose of the tRNA and their amino acid activation 
domains are built from antiparallel sheets36.  
A possible origin of class-specific hydroxyl group recognition was proposed by 
Ruff37 (1991) noticing that the Gln-specific aaRS from class I and the Asp-specific 
aaRS from class II approach their cognate tRNAs from opposite sites of the acceptor 
stem. Further evolutionary implications concerning the origin of the genetic code 
were discussed by Moras38. At the beginning of the progenate era there was no 
genetic code and only peptide-specific proto ribosome within an RNA world39, 40, 41, 
42 . One could imagine a primitive protein synthesis mechanism where a simple 
ribose molecule would sustain the peptide chain during elongation. A crude 
polypeptide synthetase reaction could constitute the transfer from the 2´OH group to 
the 3´OH and vice versa. In the second step, functions were dissociated into 
polypeptide synthetase and peptidyl transferase. Proteins would begin to take over 
the peptide synthetase. In the third step the protein synthesis machinery would grow 
in complexity, lending to a genetic code and the need for an interface and transfer 
molecules. The primordial synthetases, limited to the active site domain, would then 
follow parallel courses of evolution. By selecting the amino acid on one side and the 
transfer RNA on the other, amino acid tRNA ligases would lie at the origin of the 
genetic code. Lately new results for the function of aaRS to tRNAaa pairs has led to 
addition of 70 unnatural amino acids (UAAs) to the genetic codes of E. coli, yeast, 
and mammalian cells43. Because they are not found in the canonical 20 amino acids 
they provide new opportunities to generate proteins with novel properties for 
protein structure and function. 
The enzymes vary in subunit structure and molecular weight. They are separated 
into four different types of structures: and  Subunit organization of 
aaRSs is related to their separation into two classes on the basis of catalytic domain 
structure and short sequence relationships44. Class I (ArgRS, CysRS, GluRS, GlnRS, 
IleRS, LeuRS, MetRS, TrpRS, TyrRS and ValRS) are mostly monomeric and contain a 
catalytic domain with a Rossmann fold consisting of a / -sheet with six parallel 
strands and five helices45. Class II (AlaRS, AspRS, AsnRS, GlyRS, HisRS, LysRS, 
PheRS, ProRS, SerRS and ThrRS) includes  and the catalytic domain is 
based on a seven-stranded antiparallel -sheet flanked by three helices (Fig. 4). 
Information about 3-D structure comes from X-ray crystallography of these enzymes 
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specific for Gln, Met46, Tyr47 in class I and Asp48 Ser49 in class II as well as enzyme-
tRNA complexes specific for Gln50,51, Asp37,52,53 , Ser54,55 and Phe56. 
Some preliminary results about crystal data for LysRS from yeast57 was obtained in 
our research group at the beginning of these 3-D structure determinations58,59,60 . 
Also the MetRS from E. coli was reported only as a modified fragment after 
proteolytic treatment with trypsin 58. This was crystallized at almost the same time. 
They also had one reference to the results from LysRS  from yeast57. 
Some years afterwards the use of this monomer fragment from the MetRS dimer was 
reported fully active for Met and tRNAMet 61,62,63. Also the complex between this 
tryptic fragment of MetRS together with the energy rich ATP was crystallized several 
years later64. More recent report for LysRS65 and aaRS family66,67. 
 
4.1.4. Amino acid tRNA ligase - tRNA recognition 
 
There are only 20 different aaRS each specific for one amino acid. Because there are 
more than one tRNA specific for the same amino acid (the degeneracy of the genetic 
code) each aaRS must recognize more than one tRNA but still specifically 
aminoacylate tRNAs with different anticodons. The interaction between aaRS and its 
cognate tRNA occurs in two steps. The first is a diffusion-controlled bimolecular 
association between protein and nucleic acid. The second is a unimolecular 
conformational change of the initially formed aaRS-tRNA complex. In order to 
discriminate between cognate and noncognate tRNAs, the aaRS can use "dual 
discrimination" or a two-part process for recognition specificity. This means that in 
the first part Km (binding step) is much higher for noncognate complexes and Vmax 
(catalytic step) several 1,000-fold lower for the noncognate aminoacylation. In the 
second part in a homologous system noncognate complexes can have dissociation 
constants 100-fold or more higher than that of the cognate complex. Considerable 
effort has been directed at locating (on the tRNA) regions that are important for 
binding of aaRS68. 
Two major conclusions from this work are: 
1. A bound ligase makes contact with diverse areas of the structure. The aaRS may 
simultaneously contact the anticodon, the 5'-side of the DHU-stem, and the acceptor 
terminus. 
2. Most of the ligases bind along and around the inside of the L-shaped structure.  
The various parts of the aaRS that are in contact with its specific tRNA substrate have 
been described by Cavarelli69 and Moras and Delarue70 and Moras. Specific identity 
elements in tRNAGln and tRNAAsp in recognition of their aaRS have been found by 
Frugier71. Communication between the anticodon recognition site and active site 30 
Å away is reported by Weygand-Durasevic72. A 17 amino acid-loop in GlnRS 
(residues 476 to 492) that connects two -ribbon motifs span the anticodon binding 
domain and extend to the active site. The influence of a specific amino acid, Ala 294 
within the motif 3 consensus of the -subunit in PheRS from E. coli, especially as a 
determinant of the amino acid binding pocket size is investigated by Ibba73. 
Replacement of Ala 294 by either Gly or Ser, thereby increasing or decreasing the size 
of the binding pocket, respectively, reduces affinity for Phe. Lately the evolutionary 
process of aaRS is discussed by Ibba74 and Woese75 also for the two different classes I 
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and II . The special role of aaRSs for translation is discussed by Ibba76 and 
Schimmel77. Different deseases depending on the affected aaRS involved in genetic 
information from mitochondrial DNA disorders as disease genes. Especially the 
initiation of mitochondrial protein synthesis by charging tRNAs with their cognate 
amino acids in the oxidative phosphorylation system is essential in the process of 
transferring genetic information from mitochondrial DNA78, 79, 80, 81. 
 
 
4.1.5. Protein synthesis on the ribosome 
 
The bacterial (E. coli) ribosome consists of one large subunit (50S) and one small 
subunit (30S). The whole ribosome has a molecular weight of 2.5x106 (70S). In 
eukaryotic cells corresponding figures are 60S and 40S for the subunits, and 80S for 
the whole structure. Both subunits consists of rRNA as well as proteins. Protein 
synthesis can be separated into three parts: initiation, elongation, and termination. 
Initiation starts with formation of a 30S initiation complex. This complex consists of 
the 30S ribosomal subunit, mRNA, formylmethionyl-tRNA (fMet-tRNA), and GTP. 
Three protein factors82 specifically contributes to complex formation: IF-1, IF-2 and 
IF-3 . 
Elongation consists of aa-tRNA binding, peptide bond formation, and translocation. 
Two specific proteins, Tu and Ts (or EF-Tu and EF-Ts), are involved in the process on 
the ribosome where aminoacyl-tRNA (aa-tRNA) binds to the ribosome83 . Binding of 
aa-tRNA can be represented by 4 equations: 
 
1. Tu.GTP + aa-tRNA            > Tu.GTP.aa-tRNA  
2. Tu.GTP.aa-tRNA.ribosomes      > Tu.GDP + Pi + ribosome bound aa-tRNA 
3. Tu.GDP + Ts            > Tu.Ts + GDP  
4. Tu.Ts + GTP             > Tu.GTP + Ts.  
 
An older model of tRNA binding at the ribosome used only two sites: the A 
(aminoacyl) site and the P (peptidyl) site. Now the model seems more complicated 
(or complex) when these sites are handled between the ribosome's subunits in hybrid 
sites 19 as the tRNA moves from the A/T (or Tu mediated interaction) via A/A, A/P, 
P/P, P/E, and E sites. This translocation process may involve relative movement of 
the large and small subunits, explaining the two-subunit architecture of all 
ribosomes. The peptide bond formation is catalyzed by peptidyl transferase. 
Termination needs two release factors, RF1 and RF2. These are proteins which can 
recognize the three stop (or termination) codons. RF1 recognizes UAA or UAG and 
RF2 recognizes UAA or UGA. The binding of RF1 and RF2 to a stop codon managed 
by a third release factor, RF3, and GTP 19 somehow activates peptidyl transferase so 
that it hydrolyzes the bond between the polypeptide and the tRNA. The specificity of 
peptidyl transferase is altered by the release factor so that water rather than an amino 
group is the acceptor of the activated peptidyl part. The 70S ribosome then 
dissociates into 30S and 50S subunits as the prelude to the synthesis of another 
protein molecule. The interaction between tRNA, rRNA and peptidyl transferase has 
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been discussed by Noller84, 85 . The main interactions between tRNA and rRNA 
involve the extremities of tRNA: the anticodon stem/loop with 16S rRNA and the 
CCA terminus with 23S rRNA. One or more ribosomal proteins are involved in 
catalysis. They are responsible for maintaining the compact three-dimensional 
folding of 23S rRNA. Peptidyl transferase activity depends on this compact folding. 
 
 
4.2. Methodologies used for characterization 
 
4.2.1. Physico-chemical methods 
 
 
The quaternary structures of some of the 20 different aaRSs were determined in our 
research group in the middle of 1970 (Paper I - IV). The structure is important for the 
function of these enzymes in the recognition of their tRNA-substrates. The 
quaternary structures of aaRSs from prokaryotes and eukaryotes are discussed by 
Mirande86. The quaternary structures of these enzymes were determined by  
examining the size of their possible subunits by means of molecular weight (Mr) 
determinations. Some of these Mr:s are determined from completed primary 
sequences so a comparison of these Mr:s determined with different analytical 
methods is now possible. 
The knowledge of primary sequences of numerous aaRSs from various sources and 
gene technology is necessary in order to delineate the domain structures of these 
enzymes. Primary sequences are required in order to be able to point out specific 
features acquired during evolution from bacteria to mammals. In prokaryotes the 
complete primary sequences of 18 aaRSs were determined by gene cloning and 
sequencing. For those aaRSs that contain the amino acid sequences HIGH (His-Ile-
Gly-His) and KMSKS (Lys-Met-Ser-Lys-Ser) the polarity NH2-HIGH--KMSKS--
COOH is conserved. As these two segments seem to be involved in the formation of 
the active site, this implies a common folding pattern, the carboxy-terminal moiety 
folding back upon the aminoterminal domain. The importance of these consensus 
sequences for ATP-binding is also mentioned by other authors87, 88. 
This thesis Paper I-IV concerns the structure determination of the following aaRSs : 
LysRS and ValRS from S. cerevisiae (yeast), LysRS, AspRS, andSerRS from E. coli, and 
AsnRS, LysRS89,  SerRS, and ValRS from B. stearothermophilus. Paper I is a 
continuation of earlier preparative work90, 91 . Experimental procedures are described 
in detail in Paper I or references therein. A short description will follow here. 
A good yield of enzyme was important for the various structural as well as substrate 
recognition studies. In all preparative work each step was always controlled with 
respect to specific activity as well as yield. It is not possible to obtain any information 
of the recognition mechanism between molecules from protein preparations that are 
not purified enough. Therefore, the purity of the preparations was controlled to 
obtain optimal preparative conditions. 
Different methods were used e. g. gel electrophoresis, gel chromatography, and 
analytical ultracentrifugation92. The purity of enzyme preparations was of vital 
importance for the studies of the molecular weights of the aaRSs. Enzymes which 
had not been purified enough showed a too low mean molecular mass in equilibrium 
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sedimentation determinations with the Yphantis93, 94 meniscus depletion method. 
The reason for this was that the average Mr was determined from the slope of the 
line used in the calculation of the Svedberg95 equation . 
Initially, impure enzymes gave irreproducible results when the opinion was that this 
type of enzyme should have a molecular mass close to 100,000. However, after some 
time there was no doubt that different independent methods gave the same results 
showing real Mr values. Three previously purified ligases: LysRS 57, and ValRS 90 
from yeast, and LysRS 91 from E. coli could now be characterized in various respects. 
 
 
4.2.2. Purification of amino acid tRNA ligases from different sources 
 
Only one example for the purification of all aaRS´s is shown here. Frozen cells of 
yeast (Saccharomyces cerevisiae C 836) were subjected to high pressure at -25oC to 
break the cell walls. Extraction of this starting material with a large volume of Tris 
buffer (0.02 M, pH 8.0) by stirring for 30 min and centrifugation for 45 min ( at 
15,000xg) resulted in a crude extract. 
The purification of ValRS90 from yeast used the same steps described for LysRS57 
from yeast, with some modifications of amounts of substances, volumes and pH 
values. 
 
Table 1. Purification of LysRS57 from yeast.  
 
Fraction Protein 
 
mg 
Total 
Activity 
units 
Specific 
Activity 
units/mg 
Yield 
 
% 
 
 
Crude extract 
 
38,800 5.6 x 106     140 100 
Streptomycin  
supernatant 
34,600 4.2 x 106     120   75 
Ammonium 
sulfate 
  5,400 3.5 x 106     640   62 
DEAE-cellulose 
 
     460 2.2 x 106   4,800   39 
Amberlite IRP-64 
 
       48 1.7 x 106 35,000   30 
Hydroxylapatite 
 
       11 8.7 x 105 79,000   16 
 
The purification of LysRS 91, AspRS and SerRS from E. coli compared with the 
purification of the two enzymes from yeast described above nearly followed the 
same procedure. One difference was that DEAE-Sephadex was used instead of 
DEAE- cellulose. For more information about  differences in purification steps for 
AspRS and SerRS, see Paper III, Table 1. 
In the present investigation (Paper IV) several aaRS from the thermophilic organism 
Bacillus stearothermophilus were purified. We argued that the thermostability of 
proteins from this organism would favour a high recovery of native enzymes during 
the purification procedure and that stable crystals of the purified proteins, amenable 
to X-ray crystallography, would be more easily obtained. 
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The AsnRS, LysRS, SerRS, and ValRS from Bacillus stearothermophilus were all 
purified from the same batch of cells (Paper IV, Table I). A crude extract was first 
made of the cells and after an ammonium sulfate fractionation step, the enzymes 
were chromatographed on a column of DEAE-cellulose. Three fractiones were 
obtained in this step, one with LysRS, one with ValRS and one containing the AsnRS 
and SerRS. The asparagine and serine enzymes were separated using DEAE-
Sephadex chromatography. The four aaRS were then individually purified. The 
overall purification ranged from 400- to 900-fold as judged by specific activity. From 
1,000 g of cells approximately 10 mg of each aaRS was obtained. The purified aaRS 
were analyzed by polyacrylamide gel electrophoresis under denaturing conditions 
(SDS-PAGE) and all of the four enzymes appeared as a single, apparently 
homogenous band. When subjected to velocity sedimentation they formed a single 
peak. The LysRS could be obtained in crystalline form by dialyzing the enzyme 
against a solution of 1.6 to 1.8 M ammonium sulfate, containing 50 mM potassium 
phosphate. Another study of LysRS  from B. stearothermophilus came from a group 
in Japan 89.  
 
 
4.2.3. Preparation of tRNA 
 
Crude yeast and E. coli tRNA was highly purified by BD-cellulose chromatography 
of N-phenoxyacetylated aa-tRNA57. The eluent contained a low concentration of 
MgSO4 and sodium acetate buffer with a final very high concentration of NaCl and 
ethanol. A special notice concerning tRNAs comes from the studies of archaea where 
recycling of tRNAs 96 occurs with the help from aa-tRNA ligases which interact with 
the ribosome. One example of this is when aa-tRNAs after this type of production are 
selectively bound by elongation factors as EF-1 alpha in eukaryotes and archaea or 
EF-Tu in bacteria and delivered to the ribosome providing the growing polypeptide 
chain with substrates for translation elongation. The reason for this is that it is a 
limited substrate diffusion away from the ribosome by allowing rapid recycling of 
tRNAs. At the yeast ribosome the diffusion of tRNA away from the ribosome is 
slower than translation so some tRNA channeling takes place. When one given 
codon has been used to encode an amino acid during translation of a gene there is a 
strong tendency to encode the next occurrence of that amino acid using a codon that 
can reuse the tRNA that was used earlier. So tRNA molecules exiting from the 
ribosome remain associated with the translational machinery where they are 
recharged with amino acids and then readily available to be reused. Thus codon 
correlation is beneficial for the speed of translation. 
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5. THE IMPORTANCE OF THE ANALYTICAL      
ULTRACENTRIFUGE FOR ANALYSIS OF 
    MACROMOLECULES 
 
5.1. Historical overview 
 
High speed ultracentrifugation became a reality in the 1920´s. The ultracentrifuge was 
initially developed by Theodor Svedberg and co-workers in these years to study gold particle 
size distributions (Rev. 2005
97
). For his work on the ultracentrifuge, Svedberg was awarded 
the Nobel Prize for chemistry in 1926. The ratio of the sedimentation velocity and centrifugal 
acceleration is expressed in units of Svedberg (1 S = 1 x 10
-13
 s). The name Spinco stands for 
the company Specialized Instruments Corporation in USA which produced the commercially 
available Spinco Model E analytical ultracentrifuge (Fig. 9). Today the first production of 
Spinco Model E is replaced by two new commercially available analytical ultracentrifuges 
named Optima XL-A and XL-I in 1992 (Figs. 10 and 11). These are the instruments used now 
which produce digital absorbance data. They are smaller and more easily maintained and 
serviced.  
 
 
5.2. Technical aspects 
  
Since the time with high production of analytical results from the use of Spinco Model E the 
interest was slowly reduced until the new Optima XL-A and XL-I could take over. Then the 
production of analytical results raised to the former level again and only between 2004 to 
2014 with 2100 published papers on the use of analytical ultracentrifugation (Figs. 12 and 13) 
to assess the solution for mass, size, shape and association of macromolecules
98
.  
 
The new system is used with monochromatic light from a Xenon flash lamp and the final 
registration with a Photomultiplier tube for the absorbance based optical system. The 
Interference optical system has a Laser light source and uses Rayleigh Interference optics with 
a computer-controlled CCD camera detection system. Data are analyzed using specialized 
software on an associated computer
99
. 
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Fig. 9. Spinco Model E Analytical Ultracentrifuge . 
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Fig. 10. Optima XL-A Analytical Ultracentrifuge 
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Fig. 11. Optima XL-I Analytical Ultracentrifuge  
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Fig. 12. Published  Items in Each Year for “Analytical Ultracentrifugation”. 
 
 
 
 
 
 
 Fig. 13. Citations in Each Year for “Analytical Ultracentrifugation”. 
 
 
 
 
 
Then the methods Sedimentation Velocity and Sedimentation Equilibrium were used as 
before but not manually registered because it was done digitally instead with computer 
directly in these new instruments
100
. The optical system was also changed from the old UV 
light source which could be used with the Schlieren optics (Figs. 14 and 15) or Rayleigh 
Interference optics (Figs. 16 and 17) with the change of special constructed parts between the 
light source and the lenses before the final registration was done on the film.  
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Fig. 14. Sedimentation concentration gradient results in Schlieren peak.  
 
 
 
 
 
Fig. 15. Photographs (3 out of 6 possible) with Schlieren Optics of Sedimentation Velocity on 
Kodak Metallographic glass plate. 
 
 
Velocity Sedimentation of purified Lys tRNA ligase
91
. Schlieren pictures were taken at a bar 
angle of 60° after 8, 40 and 64 minutes of centrifugation at 59,780 rev./min. The protein (7.15 
mg per ml) had been dialyzed against 0.1 M potassium phosphate buffer, pH 7.5. 
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Fig. 16. Rayleigh Interference Optics. 
 
 
 
 
Fig. 17. Final photo with Interference Optics of Sedimentation Equilibrium on Kodak 
Spectroscopic II-G glass plate.  
 
 
 
Light and Dark Bands within Diffraction Envelope (picture above). 
 
Typical Interference Pattern (picture below). 
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5.3. Present state of analytical ultracentrifugation 
 
In this received paper
101
, is given and outlined the Open AUC Project. Improvements are 
needed for the next generation of AUC-based research. A new base instrument is described, 
one that is designed from the ground up to be an analytical ultracentrifuge. 
This ultracentrifuge will be equipped with multiple and interchangeable optical tracks with 
electronics and improved detectors available for a variety of optical systems. The instrument 
will be complemented by a new rotor, enhanced data acquisition and analysis software, as 
well as collaboration software. The instrument, the modular software components, and a 
standardized database that will encourage and ease integration of data analysis and 
interpretation software is described. 
 
 
5.4. Analytical methods 
 
5.4.1. Sedimentation equilibrium with analytical ultracentrifuge  
 
These determinations were done with the analytical ultracentrifuge. According to 
Yphantis 93 the experimental results gave values of  calculated from the equation: 
 
= d(ln c)/d(r2/2) and c is replaced by (delta y) which is received from 5 parallel 
Rayleigh interference fringes where all Y(i) - Y(0) is greater than 100 µ. 
         
where  c = concentration of sedimenting material at one point (i) in the rotor cell 
             r = radius from centre of rotation to this point (i) of sedimenting material 
 
This was possible only at equilibrium when the centrifugal force just balanced the 
frictional force or when the sedimentation and diffusion coefficients are constant. 
When this state was obtained at the centrifugation all ln c versus corresponding r2/2 
points plotted in a diagram fitted a straight line as can be seen in Paper I, Fig. 3 . 
 
From  the molecular mass was calculated from the modified Svedberg 95 equation :    
 
M = RT/ 2(1- ) 
 
where  M = Mr 
              R = gas constant = 8.314 107 (erg K-1 mol-1) 
              T = absolute temperature (K) 
               = angular velocity (rad/s) ( =  n/ 30)  and n = speed of rotation (rpm) 
               = partial specific volume of the solute (ml/g) 
               = density of solution (g/ml) 
 
 
 
 
 
 
40 
 
 
5.4.2. Sedimentation velocity with analytical ultracentrifuge 
 
These determinations were carried out with an analytical ultracentrifuge and  
s-values (sedimentation coefficients) were calculated from the equation: 
 
d(ln x)/dt = 2s and d(ln x)/dt = 1/x (dx/dt ) 
 
where  x = distance from centre of rotor axis to Schlieren peak 
             t = sedimentation time (from full speed) 
 
at different concentrations and extrapolated to zero concentration to obtain s0-values 
as well. After correction s020,w was finally obtained. 
 
5.4.3. Archibald approach to equilibrium 
 
The experimental details concerning this type of analytical ultracentrifugation is 
explained by Ehrenberg102 . The ratio between sedimentation coefficient (s) and 
diffusion coefficient (D) is obtained and used to calculate the molecular weight (Mr) 
from the Svedberg equation. This experimental approach is even confirmed by 
Trautman103 and Crampton. 
 
The Svedberg 95 equation gave: 
 
M = RTs/D(1- ) 
 
where s = sedimentation coefficient 
                  (all other symbols are explained above) 
 
it was so possible to calculate Mr with s(20,w)-values obtained from  
sedimentation velocity determinations. 
 
 
5.4.4.  Gel chromatography 
 
By means of partition coefficients, Kav was calculated from the equation: 
 
Kav = (Ve -V0)/(Vt - V0) 
 
where  Ve = elution volume 
             Vt = total volume 
             V0 = void volume 
 
and the equation by Laurent and Killander104 : 
 
(-ln Kav)0.5 = (constant) rs + constant 
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It was possible to obtain the Stokes radii rs of the enzymes from a diagram 
made by reference substances (Paper I, Fig. 4). 
Diffusion coefficients D(20,w) were calculated from the Stokes-Einstein 
equation: 
 
 D(20,w)= kT/6 rs 
 
where k = Bolzmann constant 
            T = absolute temperature 
             = viscosity 
 
 
5.4.5. Amino acid composition for partial specific volume 
 
From automatic amino acid analysis chromatography, the amino acid composition 
for the aaRS enzymes was determined. From these data the different partial specific 
volumes ( ) were calculated from the equation: 
 
 =  ni Vi Mi/ ni Mi 
 
where  ni = number of amino acids/1,000 
             Vi = volume of amino acid 
             Mi = molecular mass of amino acid 
 
When all the ni are available and corrected to Mr one can use Mr instead of ni Mi in 
the equation. 
 
 
5.6. More analytical methods 
 
5.6.1. Binding studies 
 
According to the Scatchard105 equation : 
 
/L = K( -n) 
 
where   = the average number of ligands per protein molecule 
             L = concentration of free ligand 
             K = binding constant 
             n = the number of binding sites per protein molecule 
 
A plot of /L against  gives a straight line in analogy with the linear equation  
y = kx, and /L = 0 when  = n which is the intercept on the abscissa. 
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The theory is based on the fact that when free ligand is dialyzed through a 
membrane until its concentration across the membrane is at equilibrium, a direct 
measurement of free ligand concentration L is possible.  is calculated from 
concentration of bound ligand divided by protein concentration (= binding 
component). The concentration of bound ligand can be obtained from the equation:  
 
starting concentration of ligand = final concentration of free ligand + 
(final concentration of free ligand + concentration of bound ligand) 
 
Concentrations in parentheses are found on one side of the membrane. 
 
 
5.6.2. Cicular dichroism measurements 
 
From the experiments performed in a recording spectropolarimeter values were 
calculated according to the equation: 
 
 [  =  MRW/10 l c  
 
where  [  = mean residue ellipticity (in units of degrees cm2per decimole) 
                     = wave-length (in nm) 
                 = observed ellipticity (in degrees at ) = (ODL - ODR)  33              
          MRW = calculated mean residue molecular mass (see below) 
                    l = pathlength of light through the cell (in cm) 
                    c = protein (or other solute) concentration (in g/ml) 
 
MRW was calculated from the equation: MRW = Mr/n 
 
where   Mr = molecular mass (molecular weight) 
                  n = total number of amino acid residues 
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6. RESULTS AND DISCUSSION 
 
6.1. Structural and conformational determinations of ValRS, and LysRS              
       from yeast, and LysRS from E. coli 
 
The native Mr of ValRS from yeast determined by equilibrium sedimentation  and 
the value calculated from diffusion coefficient (by gel chromatography) and 
sedimentation coefficient (by sedimentation velocity determination) (Paper I). These 
Mr-values can be compared with the preliminary results obtained some years before 
with Mr for the native enzyme estimated by approach to equilibrium106 and 
calculated from sedimentation coefficient and diffusion coefficient90. Another study 
with Archibald approach to equilibrium 90 at the same protein concentration, 3.5 mg 
per ml, and at a protein concentration of 6 mg per ml were lower. We concluded that 
the true Mr for the native enzyme was derived from equilibrium sedimentation 
determinations described in Paper I shown in Table 2. This value is also in good 
agreement with the calculated value from amino acid sequence. From gel filtration 
determination, Chatton107  obtained an Mr-value in good agreement with our result 
for the native enzyme. 
The possible subunit Mr was determined by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) with gel chromatography in 6 M GuHCl with DTT, and with 
equilibrium sedimentation in 6 M GuHCl with DTT. The different values are 10,000 
too low for the former and 10,000 too high for the latter. In comparison with Mr-
values from subunit determinations as well as from the native enzyme we concluded 
that this enzyme is a monomer of the type. 
Mr-determinations for LysRS from yeast in its native form studied by equilibrium 
sedimentation resulted in different values depending on the time between 
preparation and determination  (Paper I). We concluded that the most freshly 
prepared enzyme gave the true value with no contribution from low molecular 
weight split material. The calculated Mr-value obtained by diffusion coefficient and 
sedimentation coefficient was in agreement with the true value  determined with 
equilibrium sedimentation. This value is also in close agreement with the calculated 
value from amino acid sequence. The preliminary Mr-results for this enzyme with 
approach to equilibrium 106 were much lower .  
Mr-values from subunit structure determinations obtained with different analytical 
methods gave the results shown in Table 2.  These values may be compared with the 
subunit Mr-values reported by Mirande108 and Waller, and Cirakoglu109 and Waller, 
confirming our results. All these subunit values show a quaternary structure for the 
enzyme corresponding to a homodimer of the 2-type. 
The Mr-values for the native enzyme LysRS from E. coli are presented with methods 
and results for equilibrium sedimentation as well as for diffusion coefficient and 
sedimentation coefficient determination with calculated value (Paper I). The 
calculated value from amino acid sequence is much higher and agree with two times 
of the subunit value from gel chromatography in 6M GuHCl. Preliminary Mr-results 
83 with Archibald approach to equilibrium91 were close to ours. 
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Mr-values determined for the subunit gave the results for SDS-PAGE and with gel 
chromatography in 6 M GuHCl as well as the equilibrium sedimentation in 6 M 
GuHCl with DTT. The various Mr-values are summarized in Table 2. 
The quaternary structure of this enzyme must obviously be a homodimer and we 
concluded from these results that it must be of the 2-type.  
 
Table 2. Molecular weights (Mr) for ValRS, and LysRS from yeast, and LysRS 
               from E. coli. 
 
Enzyme Mr , native. 
(equilibrium  
sedimentation)  
 
Mr, native. 
(calculated from  
s/D) 
Mr, subunit. 
(SDS-PAGE) 
Mr, subunit. 
(equilibrium  
sedimentation in  
6M GuHCl) 
 
 
ValRS (yeast) 122,000 113,000 112,000 134,000 
LysRS (yeast) 138,000 138,000   72,000   74,000 
LysRS (E.coli) 104,000 108,000   62,000   54,000 
 
Mw, 
calculated from  
amino acid 
sequence 
 
 
125,770 
135,918 
115,654 
 
 
6.2. Determination of binding sites 
 
As soon as the quaternary structures were known it was possible to make 
conclusions about binding sites which could give valuable information about the 
way these enzymes recognize their tRNA substrates. The quaternary structure 
examinations were supported by binding experiments which resulted in one site 
each for Val and ATP in ValRS from yeast but two sites each for Lys and ATP in 
LysRS from yeast and from E. coli. 
Km-values for LysRS from yeast and E. coli with tRNA substrates were calculated 
(Paper I, Fig. 2). It can be seen from Paper I, Fig. 8, that LysRS from yeast and E. coli 
binds two molecules of lysine per enzyme molecule. ValRS from yeast  has  only one 
binding site for valine. The same result with regard to the number of binding sites 
was obtained with ATP as ligand. 
 
 
6.3. Thiol group determination of enzyme-ligand complexes 
 
The Ellman110 reaction described as: RS- + DTNB → RSTNB + -TNB, was used to 
examine how many thiol groups that was needed (or hidden) in different enzyme - 
Enzyme Mr, subunit. 
(gel chromato- 
graphy in 6M  
GuHCl) 
 
 
ValRS (yeast) 114,000           
LysRS (yeast)   70,000 
LysRS (E.coli)   58,000 
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ligand complexes (Paper II, Fig. 1). Of  the 18 thiol groups obtained under denaturing 
conditions (with GuHCl) only 13 was accessible in the native state of LysRS from 
yeast. In the presence of lysine two more thiol groups were accessible but in the 
presence of tRNA at least four groups were protected. ATP and the adenylate 
complex had no effect on the enzyme in this respect. 
Of the 12 thiol groups in ValRS from yeast accessible under denaturing conditions 
only 10 could be obtained in the native state. ATP protected  nearly four groups but 
valine only one. Two groups were protected by tRNA but with the adenylate 
complex only one was protected. 
LysRS from E. coli had three reactive thiol groups under denaturing conditions. 
Therefore, the difference in accessible groups was very small. Approximately one 
thiol group was used in all ligand reactions. 
LysRS from yeast lost most of its activity when five thiol groups had reacted with 
DTNB. (Paper II, Fig. 1). For the ValRS from yeast this was true when only two 
groups had reacted. As can be seen in Paper II not much of the enzyme activity of 
LysRS from E. coli vanished in the reaction with DTNB because of its lack of 
sensitivity to thiol reagents111. As shown in Paper II, Fig. 2, out of the three enzymes 
there was a drastic effect of DTNB only on ValRS from yeast. The other two, LysRS 
from yeast and from E. coli were nearly unaffected by DTNB. The possible effects by 
DTNB on the quaternary structures of the enzymes in the native state as well as in 
forming amino acid activating complexes could not be determined. The studies were 
made (by the control of s-values) on the two LysRS enzymes from yeast and E. coli 
which were known to consist of subunits. 
 
 
 
6.4. Conformational changes 
 
Would it be possible that the enzymes changed their conformational structure upon 
binding substrates? If there is a conformational change it would show in CD-studies 
of the native enzymes as compared with those with bound substrates. The systems of 
interaction between enzyme and substrate(s) were: 
 
 
1. Enzyme with corresponding amino acid. 
2. Enzyme with ATP, Mg2+ and amino acid. 
3. Enzyme with corresponding tRNA and Mg2+. 
 
These conditions were tested with ValRS, and LysRS from yeast, and LysRS from E. 
coli. The value  of  in all these experimental determinations was 220 nm, the 
wavelength of one of the possible negative peaks, because there the conformational 
change of the enzyme would contribute most. The main reason for this is that all 
substrates tested had no contribution at that wavelength112 . At the wavelength 220 
nm all three enzymes showed negative Cotton effects which is expected for -helix 
content and the transition is n- * 113 with non-conservative contribution from the 
peptide bond114.  
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When system 2 was tested with LysRS and ValRS, both from yeast, a slight difference 
was observed from the curve of the enzyme alone, which was not additive from the 
components used. This was further tested with EDTA replacing Mg2+. When system 
3 was tested for LysRS from yeast and E. coli also a slight difference occurred from 
the curve of the enzyme alone, which was not additive from the components used. 
All determinations were carried out at room temperature (after storage of enzymes 
and substrates on ice), at pH 7.0.  
It was very hard to draw conclusions from the above studies because no drastic 
changes could be seen. When the ellipticity at 220 nm was used in -helix content 
calculations for all three enzymes shown in Paper II, Fig. 3, the following figures 
were obtained for % right-handed -helix: 24% in LysRS from yeast, 16% in ValRS 
from yeast, and 25% in LysRS from E. coli. 
The differences mentioned above were 2.6% more -helix for LysRS from yeast, and 
4.2% more -helix for ValRS from yeast, in system 2, which means a conformational 
change of 11% for LysRS from yeast, and 26.6% for ValRS from yeast. 
In system 3, the differences were 2.6% less -helix for LysRS from yeast, and 2.1% 
less -helix for LysRS from E. coli, which means a conformational change of 11.0% for 
LysRS from yeast, and 8.3% for LysRS from E. coli. 
These results are comparable with those obtained by  Ehrlich115 . The enzyme PheRS 
from yeast used by Ehrlich contains roughly twice the -helix content compared with 
ours so a small difference in -helix content in our enzymes will therefore result in a 
relative large  calculated conformational change. The result in our case is the same as 
theirs with a decrease in -helix content of the enzyme upon binding its tRNA-
substrate. 
 
 
 
6.5. Structural determinations of AspRS and SerRS from E. coli 
 
To continue the investigations of other amino acid specific aaRSs from E. coli we 
purified eight different aaRSs from the same batch of E. coli (Paper III). Two of them, 
AspRS and SerRS, were especially characterized in terms of their molecular 
parameters. SerRS was examined by Katze 116 and Konigsberg  at that time and 
published by them, so we did not publish our results for that enzyme, but for the 
sake of completeness these are discussed in this thesis. The purification procedures 
are described in Paper III and purification data are shown in Table 1 therein. 
The Mr-value for the native enzyme AspRS determined with equilibrium 
sedimentation and from calculation (gel filtration and sedimentation velocity) shown 
in Table 3. Also subunit determination with SDS-PAGE  and with equilibrium 
sedimentation in 6 M GuHCl with DTT in there. These values may be compared with 
subunit later obtained by Eriani117 in agreement to ours. 
Thus, the enzyme must be a homodimer with a quaternary structure of the 2-type. 
The Mr-value for the native enzyme SerRS from equilibrium sedimentation was 
exactly the same obtained by gel filtration and sedimentation velocity 
determinations. The equilibrium sedimentation Mr-value from Katze116 and 
Konigsberg was slightly lower. Subunit determination with SDS-PAGE and 
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equilibrium sedimentation in 6 M GuHCl with DTT gave Mr values slightly higher 
compared with the values received from Katze116 and Konigsberg. A similar value 
was derived by Härtlein118. 
These results agree well with the opinion that the quaternary structure of the enzyme 
is a homodimer of 2-type.  Mr-values are summarized in Table 3. 
We obtained  the same broad pH optimum at pH 8.5 for AspRS and SerRS in 
agreement with Katze 116 and Konigsberg  for SerRS. Their Km-value for the 
corresponding  amino acid at two different pH-values is in good agreement with 
ours at pH 7.0 for both enzymes but their Km value for ATP seems to be 5 times too 
high. 
The aa-AMP complex forming ability was 60% for AspRS assuming one active site 
per enzyme molecule, and for SerRS this ability was 55%. 
 
Table 3. Molecular weights (Mr) for AspRS, and SerRS from E. coli. 
 
 
Enzyme Mr , native. 
(equilibrium 
sedimentation) 
Mr,  native. 
(calculated from 
 s/D) 
Mr,  subunit. 
(SDS-PAGE) 
Mr,  subunit. 
(equilibrium 
sedimentation in  
6M  GuHCl) 
 
 
AspRS(E.coli) 119,000 132,000 64,000 61,000 
SerRS (E.coli)   99,000   99,000 54,000 53,000 
 
 
 
Mw calculated from amino acid sequence for AspRS (E.coli) 131,826. The native value 
from equilibrium sedimentation is 10,000 lower than the real value calculated from 
s/D. This is because of the 60% part in Fig. 4 in Paper III has been contaminated from 
the minor part in the chromatogram showed in this Fig.4. The s/D value is not this 
sensitive from Schlieren peak determination for s in velocity sedimentation.    
Mw calculated from amino acid sequence for SerRS (E.coli) 96,828. This native value 
is in good agreement with both equilibrium sedimentation and s/D calculation. 
 
6.6. Structural determinations of AsnRS, LysRS, SerRS and ValRS from  
       B.  stearothermophilus 
 
Besides the main reason to provide enzymes suitable for crystal studies, it was 
interesting to examine especially thermostable enzymes from B. stearothermophilus in 
a high temperature kinetic point of view. 
Purification steps in Paper IV, Table I. The characterization of all enzymes but one, 
ValRS, already determined by Koch119  is found in Paper IV, Table III and IV. 
All the purified enzymes were characterized with respect to molecular weight (Mr) 
and subunit structure. The data for the ValRS is not shown in Paper IV since this 
enzyme had already been studied by Koch 119.  
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In the calculations of Mr for Paper IV, Table IV the partial specific volumes from 
amino acid compositions (Paper IV, Table II) were as follows: AsnRS 0.739, LysRS 
0.743,  SerRS  0.736, and ValRS  0.738 from Koch 119 not in there. 
The Mr for native enzyme AsnRS determined by equilibrium sedimentation was also 
calculated from gel filtration and sedimentation velocity. The molecular weights of 
the subunits were determined by electrophoresis in polyacrylamide gel containing 
0.1 % SDS (SDS-PAGE) (Paper IV, Fig. 4) and from equilibrium sedimentation in 6 M 
GuHCl with DTT (Paper IV, Table III). This enzyme has a quaternary structure of 2-
type. 
The Mr for native LysRS is determined by equilibrium sedimentation and calculated 
from gel filtration and sedimentation velocity. The subunit Mr is received from SDS-
PAGE and from equilibrium sedimentation in 6 M GuHCl with DTT. This enzyme 
has a quaternary structure of 2-type. 
The Mr for native enzyme SerRS is determined by equilibrium sedimentation and 
calculated from gel filtration and sedimentation velocity. The subunit Mr is received 
from SDS-PAGE  and from equilibrium sedimentation in 6 M GuHCl with DTT. This 
enzyme has a quaternary structure of 2-type. 
Finally, All the data clearly indicate that each aaRS is composed of two subunits of 
equal molecular weight with the exception of the valine enzyme (ValRS) which 
consists of only one polypeptide chain of -type as already reported by Koch 119. 
Because we also determined the enzyme ValRS (unpublished) our values can be 
compared with the results from Koch119. The Mr for native enzyme was determined 
by equilibrium sedimentation and also calculated from gel filtration and 
sedimentation velocity. The subunit Mr was received from SDS-PAGE and from 
equilibrium sedimentation in 6 M GuHCl with DTT. Mr-values are showed in Table 
4. This  enzyme is obviously a monomer of -type.   
Koch 119 obtained for native ValRS a Mr with gel filtration which agreed with our 
value. The subunit value determined with SDS-gel electrophoresis and agarose gel 
filtration in 0.1% SDS resulted in Mr 10,000 too high reported by Mirande 86. They 
also concluded this enzyme to be a monomer of -type. 
Our calculated Mr value for ValRS obtained by Sephadex G 200 filtration for D-value 
and s-value determinations is nearly the same as that from Koch 119 obtained by gel 
filtration. The subunit Mr value found after SDS-PAGE was nearly 10,000 too low, 
but Koch 119 instead got a value 10,000 too high compared with our value. 
For two enzymes, LysRS and ValRS, a special study of temperature inhibition was 
made. The conclusion was that the highly thermostable enzymes showed 
temperature dependent inhibition best explained by a conformational change of the 
enzymes (Paper IV, Figs. 5 to 7). We also studied the four purified enzymes with 
respect to their catalytic properties at high temperatures. They were all highly 
thermostable so that the aminoacylation rate as a function of temperature could be 
studied in the temperature range 25-70 °C. In Arrhenius plots the enzymes showed a 
marked deviation from linearity In the temperature range of 50-70 °C. This inhibition 
effect was not related to tRNA melting as measured by hyperchromicity. On the 
other hand, the Km values for ATP and amino acid increased sharply in this 
temperature range in contrast to the Km values for the tRNA substrate which showed 
only the expected gradual increase with temperature.  
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Furthermore, the ATP pyrophosphate exchange reaction is also inhibited at elevated 
temperatures. The inhibition observed could be explained by a conformational 
change of the enzymes which lowers both the catalytic activity and the substrate 
affinity of the ATP and amino acid sites. Because the binding sites for ATP and 
amino acid were more affected by the temperature induced conformation than the 
binding site for tRNA, this may mean that the tRNA-binding site is more located on 
the outer surface of the enzyme, whereas the other binding sites are located more 
inside. 
The LysRS from B. stearothermophilus was crystallized but showed too low resolution 
(8 Å) which did not give data from crystallographic studies as good as those for 
LysRS 57 from yeast. Some years ago the TyrRS from the same bacterium (B. 
stearothermophilus) was crystallized in the presence of Tyr and ATP and later even 
three different complexes47 between these molecules was reported. Some years 
before also for AspRS 48 from yeast. At that moment some important parameters had 
to be known before it was possible to solve the data from X-ray crystallography. One 
of these is now the molecular mass (Mr) for the four enzymes from B. 
stearothermophilus (Table 4).  
 
 
Table 4. Molecular weights (Mr) for AsnRS, LysRS, SerRS, and ValRS from 
               B. stearothermophilus. 
 
 
Enzyme Mr , native. 
(equilibrium 
sedimentation) 
Mr, native. 
(calculated from 
 s/D) 
Mr, subunit. 
(SDS-PAGE) 
Mr, subunit. 
(equilibrium 
sedimentation in  
6M GuHCl) 
 
 
AsnRS (B. stearot.) 127,000 120,000 51,000 51,000 
LysRS  (B. stearot.) 112,000 109,000 58,000 58,000 
SerRS  (B. stearot.)   88,000   81,000 51,000 49,000 
ValRS  (B. stearot.) 101,000 101,000 89,000 72,000 
 
7. SUMMARY AND CONCLUSIONS 
 
The quaternary structures of nine amino acid tRNA ligases (aaRSs) were investigated 
with different analytical methods. It was of utmost importance that the enzyme 
preparations were extremely pure, that is, no low molecular weight (Mr) from split 
material contribution was allowed. Another experience was that only freshly 
prepared enzymes showed true molecular weights (Mr) high enough and with 
reproductive results. 
The subunits comprising the quaternary structures were investigated in two different 
media: SDS and 6M GuHCl containing DTT for reduction. 
Out of the nine aaRSs seven comprised two identical subunits, 2-type homodimers, 
and the other two were -type monomers. These results were confirmed by binding 
studies with amino acid, ATP and tRNA ligands.  
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Enzymes comprising two subunits had two sites each for these ligands whereas in 
the monomeric enzymes only one site each could be found. 
Conformational changes in aaRSs when they form enzyme-substrate complexes were 
examined with three of the studied enzymes by means of CD-determinations of -
helix content. No drastic changes could be seen but two of the enzymes showed more 
-helix upon binding amino acid and ATP and two of the enzymes showed less -
helix upon binding tRNA. Studies of LysRS from yeast with its interaction to tRNA 
has been studied by Österberg120. 
Conformational changes in two other aaRSs of the by temperature inactivation 
studied enzymes from B. stearothermophilus showed a more temperature-induced 
conformation for amino acid and ATP binding sites than for tRNA binding sites. 
 
 
8. THE 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE  
    ENZYME 
  
8.1. Background 
 
“The enzymes forming the HMG-CoA leading to ketone bodies occur in the mitochondria, 
whereas those responsible for the synthesis of the HMG-CoA that is destined for cholesterol 
biosynthesis are located in the cytosol. Their catalytic mechanisms, however, are identical.” 
(Voet,D. & Voet,J.G. ,BIOCHEMISTRY,3
rd
 ed. (2004),p. 943, John Wiley & sons, inc. USA) 
 
HMG-CoA lyase (HMGL) activity is present in Rhodospirillum rubrum cells grown 
anaerobically in the light with leucine as the carbon source
121
 (Paper V). A 1.2 kb long DNA 
segment from R. rubrum was sequenced (GenBank accession number: U41280; Ref. 1). This 
is the first identified gene for a 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase, from a 
photosynthetic organism. The gene encodes a 303 amino-acid-long protein with a calculated 
molecular weight (Mw) of 31.1 kDa. 
In humans, HMG-CoA is an intermediary product of the extrahepatic catabolism of leucine. 
In mammalian mitochondria, HMG-CoA lyase is involved in formation of acetyl-CoA and 
ketone bodies (primarily acetoacetate) from HMG-CoA
122
. Acetoacetate and its metabolites 
are used as metabolic “fuel” in, e.g., heart, brain and kidney tissue. 
HMG-CoA is also an intermediate in cholesterol biosynthesis
123
, suggesting that HMG-CoA 
lyase could play a role as regulator of this pathway. Interestingly, HMG-CoA is implicated in 
hypercholesterolaemia and heart disease in humans due to the above mentioned involvement 
in cholesterol metabolism
124
. 
HMG-CoA lyase deficiency is an inherited disease where the subjects are lacking this enzyme 
activity as a result of the production of a truncated protein. This deficiency results in 
hypoglycaemia, disability to form ketone bodies and inhibition of leucine 
breakdown
125,126
,
127
,
128
 ,
129
. 
 
8.2. Experimental 
 
8.2.1. Growth of cells 
 
Rhodospirillum rubrum (strain S1) cells were grown anaerobically in the medium
130
. The 
experiments are described (Paper V, Figs. 7 and 9). 
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8.2.2. Clone isolation 
 
To study the enzyme activity of the HMG-CoA lyase from R. rubrum the plasmid pÅS6 was 
used. It is the vector pET3a with the hmgL gene as insert, behind the inducible T7 promoter. 
The pÅS6 plasmid was chemically transformed into competent bacteria cells of E. coli 
BL21(DE3)pLysS. The over expression of the enzyme was started by the induction with 
IPTG.  
To check the HMGL enzyme activity the transformed bacteria which had been grown and 
induced in the (LB+Amp) medium were used. Also as positive control Acetyl-CoA was used.  
The enzyme activity for HMGL was analysed in the spectrophotometer through the 
production of NADH at the wavelength of λ= 340 nm.  
 
The A.L.F. DNA sequencing reaction was used to check the plasmid pÅS6 and the hmgL 
gene in the vector pET3a and also the vector itself  the PCR reaction was used with the T7 
promoter primer (Forward) and T7 terminator primer (Reverse). These two primers together 
with  the hmgL gene were also checked with A.L.F. sequencing when M13 fluorescence 
primers Forward (FP) and Reverse (RP) were used. Also primers for the middle of hmgL gene 
Forward and Reverse were used. 
The DNA product after the PCR amplification was used for ligation into the vector pZErO 
digested with EcoRV and transformed into  E.coli TOP10F´. The following plasmid 
preparation resulted in the pZErO vector with the hmgL gene (pZErO/hmgL). This plasmid 
was also checked with A.L.F. equipped with Argon laser (instead of the former He-Ne laser) 
this time. 
A new protein expression system with the name IMPACT I (New England Biolabs, Inc.) was 
used from now on which could also give the possibility to use Western blot to identify the 
protein with a special anti-serum. The new vector to be used was pCYB1 which could 
combine the hmgL gene with a DNA sequence named Intein to receive a fusion protein from 
these two parts. The Intein tag on the fusion protein could be identified with anti-Intein serum 
in Western blot. The Intein part could later on be cleaved off with DTT from this fusion 
protein. 
To get this DNA construction the two parts were received as: 
 
1. pCYB1/NdeI/SapI (vector) and 2. pZErO/hmgL/ NdeI/SapI (insert) 
 
These two parts with vector and insert were ligated with T4 DNA ligase to receive the 
plasmid pCYB1/hmgL which was chemically transformed into competent bacteria cells E. 
coli BL21(DE3)pLysS. Because this use of E. coli bacteria was not successful it was 
necessary to use the new recommended strain for IMPACT I instead. We received then E. coli 
K12 ER2267 as competent cells to be used for the vector pCYB1 and the plasmid 
pZErO/hmgL. The pCYB1 is Amp
r
 and the bacteria with this part can be grown in the 
(LB+Amp) medium. The pZErO is Kan
r
 and therefore the bacteria with this part can be grown 
in the (LB+Kan) medium instead. To finally check the protein over expression after the 
induction with IPTG it was now possible to use Western blot with anti-Intein anti serum 
(from rabbit) to detect the fusion protein (HMGL+Intein with CBD) where CBD is a Chitin 
Binding Domain part from Intein. Later on  it was possible also to use anti-CBD anti serum 
because of this. 
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8.2.3. Automated sequencing 
 
The Automated Laser Fluorescent (A.L.F.) DNA sequencing was performed on an 
ALFexpress DNA sequencer (Pharmacia Biotech AB). The alignment was manually 
manipulated for the result (Paper V,  Fig.2, and text in there). In the recent control of the 
database UniProtKB for this hmgL gene
131
 and the amino acid sequence with 303 amino acids 
and the molecular mass 31,138 Da (last modified May1 1997-v1) it is 100% agreement. The 
entry for this sequence is P95639_RHORU. 
 
8.2.4. RNA isolation and cDNA production 
 
RNA was isolated
132
, and agarose gel electrophoresis, Northern blotting and hybridisation 
followed
133
. Total RNA treated with RNAse free DNAse I and in the presence of RNAse  
inhibitor was used for the production of cDNA with MMLV reverse transcriptase. 
 
8.2.5. HMG-CoA lyase from hmgL gene 
 
The PCR method was used for amplification of a stretch from the hmgL cDNA. One of the 
two primers used were constructed for a product of 505 bp with the complement from a 
BamHI RE site. This for the purpose to later clone the full length hmgL gene. The HMG-CoA 
lyase activity from R. rubrum grown in the media containing malate, leucine, mevalonate, or 
malate plus leucine respectively as carbon sources
134
.  
 
 
 
8.3. Recent results 
 
The next intension was to perform mutagenesis studies on HMG-CoA lyase in order to 
produce a more human like protein for the identification of HMG-CoA lyase activity 
modulators with potential therapeutic applications. In addition, overproduction would also be 
optimise to produce enough protein, both native and mutant versions, for crystallization and 
structure determination.  
This is now already solved which is reported lately
135
. Crystal structure of the recombinant 
human mitochondrial HMG-CoA lyase is received at 2.1 Å resolution. It was shown to 
contain a bound activator cation Mg
2+
 and the dicarboxylic acid 3-hydroxyglutarate (HG). 
The addition of the competitive inhibitor hydroxyglutaryl-CoA (HG-CoA)  was necessary for 
generation of uniform diffraction quality crystals. These inhibitor studies suggested that HG-
CoA is not an efficient substrate for HMG-CoA lyase
136
. In addition, crystal structures of two  
bacterial HMG-CoA lyases have been reported
137
 . 
The identification and characterization of an extramitochondrial human HMG-CoA lyase
138
 
was also reported lately. From plasmids constructed for this it was first a trial to use over 
expression of the protein in E. coli. This was not successful because of the production of 
insoluble material so instead another bacterium Pichia pastoris was used with the final 
positive result.  
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9. THE HD PROMOTER INITIATION DOMAIN SEQUENCE 
 
9.1. Background 
 
I was given the plasmid pAop2CS (C39S) 
139
 for transformation into the bacterium E. coli 
BL21(DE3)pLysS. The origin of this was pAR3038
140
,
141
 . The concentration of the 
polypeptide AntpHD  was calculated from the known amino acid sequence with 68 amino 
acids with the contributions especially from the three Trp, Tyr, and Phe which have 
absorption at 280 nm wavelength measured in the spectrophotometer.  
The  calculated molecular weight (Mw) for this AntpHD was used as 8.629 kDa with an 
isoelectric point (pI) of 10. Which means that the polypeptide will be positive of charge in a 
buffer with pH 7.5 which was used in our experiments. So the column with Bio-Rad 70 resin 
which is for  separation of positive ions is useful.                                                                                                                                                                                       
 
 
9.2. Methods and Results 
 
The first thing to do after the transformation of the bacterium E. coli BL21(DE3)pLysS with 
the DNA material in the received plasmid pAop2CS (C39S) was to check the sequence of the 
Antp gene with the mutation named Antennapedia. This was done with the A.L.F. DNA 
Sequencer from Pharmacia, Uppsala Sweden with He-Ne laser (633 nm) which emits  red 
light
142
 or with Argon laser (488 nm) which emits blue-green light from Amersham 
Pharmacia Biotech Sweden which also was used in this time. The DNA sequence of this Antp 
gene was already known
143
 and could easily be checked and compared of this reason. The 
result was correct from these examinations so it looked safe to use this transformed bacterium 
for preparation of the AntpHD with over expression by means of IPTG of the T7 system
139
. 
The opinion was that this originally received gift from the research group in Basel, 
Switzerland was exactly the same which had been used with the successful results even from 
NMR determinations 
143
 in the research group in Zürich. 
From this time and several years to come it was a very hard work to make all possible steps in 
the purification procedure extremely well performed also with many changes to receive even 
better results if possible? Nothing worked to get the received product checked finally with 
NMR. It was not until late in the year 2009 it was decided to send the DNA material from 
plasmid pAop2CS which was the gene Antp in the vector pET3c for examination to Eurofins 
MWG BIOTECH in Germany. The answer then was unexpected that no DNA material could 
be found and analysed! 
The reason was that the company used a T7 promoter primer with 3 C bases in the 3´ end and 
it should be 3 G bases as a complement for these in the T7 promoter in the pET3c vector. It 
could be seen now that one of these 3 G from the DNA bases in the plasmid vector sequence 
was missing! An unexpected information also for the analysing company Eurofins MWG in 
Germany. They also checked this result extra with one T7 promoter primer where only one C 
base out of the three in the 3´end was eliminated. Now this one could be fixed and the DNA 
sequence was received as expected! This result is in agreement with other examinations of T7 
promoters
144
,
145
,
146
,
147
 with bases checked for importance to T7 RNA polymerase 
transcription of the gene. It says that the T7 promoter with 22 bases beginning with 5´ TAA 
TAC and the following GAC TCA continues with CTA TAG GGA. Here the first G in the 
GGG sequence is numbered +1 so the final A is numbered +4. Moreover the bases from -4 to 
+5 which are the TATA and GGG AG is the initiation domain whereas the former bases from 
-12 to -5 which are the CGA CTC AC is the binding domain.  
54 
 
 
It is only two G bases where it should be three G bases in the T7 promoter sequence from +1 
to +3. All other bases in the T7 promoter are correct however. Because the three G bases 
signed +1 to +3 are from the middle of the DNA sequence for initiation of transcription
148
,
149
 
for the much later following bases in the Antp gene it is critical when one of these G bases is 
missing as it is here! Therefore no mRNA is produced and the translation from this actual 
gene to AntpHD will never occur. The importance of this part with intact three G bases was 
also noticed from DNA sequencing with the company MWG eurofins when their T7 promoter 
primer could only be fixed when they had to use one C base less in the complementary DNA 
sequence in the T7 promoter primer. However the DNA bases in the Antp gene were checked 
to be correct with ALF DNA sequencing originally. 
It was necessary to make a new DNA construction of the plasmid with the same original gene 
Antp with a correct vector with intact T7 promoter to use for over expression of the AntpHD. 
Now with the new vector pET21b for this instead. The new DNA construction which should 
be taken from the original plasmid with Antp  gene in the pET3c vector which first must be 
cut out from this and after this ligated into the new pET21b vector. Now the problem was to 
find the correct restriction enzymes (REs) for this in these two DNA  materials. It was 
necessary to use PCR with specially constructed primers to make correct RE sites for both.  
 
FP Antp (27 bp): 5´ GGG CATATG CGC AAA CGC GGA AGG CAG 3´  (for NdeI) 
RP Antp(27 bp): 5´ GGG  GAATTC TTA ACC  CGG  CTC GCC  CTT 3´ (for EcoRI) 
 
The two resulting REs were EcoRI and NdeI finally and after the fragments from the 
materials which were used were cut off  and eliminated the pET21b was now changed to 
pET21a with 5 Pro instead of 6 His because of the change of reading frame in the received 
DNA sequence. Then the procedure with a Ni column for production of AntpHD could not be 
used instead of the column with Bio-Rad 70 resin. The Work with this procedure which were 
used before 
139
 is still going on to receive material for AntpHD examinations pure enough and 
with the correct concentration for a new determination with mass spectrometry or even NMR. 
Later on also for binding experiments. 
 
 
9.3. Concluding remarks 
 
The homeobox genes which regulates nuclear proteins that acts as transcription factors during 
normal development are DNA sequences originally identified in Drosophila 
3
.  These proteins 
have different HD and are recognizing and binding sequence-specific DNA motifs. The 
specificity of this binding has the effect to activate or repress the expression of downstream 
effector target genes 
2
. The class I HD (Hox genes) is mentioned in embryonic development 
and in the control of cell proliferation which can result in pediatric cancers as abnormal 
development of human congenital, somatic, and metabolic defects involving mutations in 
homeobox genes. The mechanism for Hox proteins in binding to DNA in multiprotein 
complex
150
 is also studied. Early mammalian embryonic development with the stem cell 
transcription factor Nanog
151
, 
152
 is also reported. 
To continue the comment in introduction about different fields for HD effects it can be 
noticed that the studies with mice have given valuable information concerning “mechanisms 
regulating insulin secretion and metabolism in related diseases such as obesity and type 2 
diabetes”153. Here the LIM-HD transcription factor isl-1 in the pancreatic endocrine cells is 
involved in both islet development and insulin secretion together with leptin in some way.  
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It has also come new information concerning the participation of HD as AntpHD for CD8
+ 
 
Cytotoxic T Lymphocyte cells (CTL)
154
 for treatment of patients with cancer. It was the effect 
of transport into liposomes into the endoplasmic reticulum with the soluble AntpHD  
recombinant peptide which can induce T cell responses and this effect can be used as vaccine 
in this way. It has also been studies of the DNA binding human HD oncoprotein HOX11 as 
transcription factor for spleen development in embryogenesis. It is also associated with T cell 
acute lymphoblastic leukemia
155
 in children. So HOX11 has a functional role in both normal 
development and  malignancy. A special nuclear oncoprotein TLX1/HOX11 is studied with 
leukemic T cells
156
. Another homeobox protein MSX2 is studied for malignant melanoma
157
. 
Since the early studies in evolution reported from Charles Darwin (Darwin, Ch. 1859) the 
studies of eye evolution
158
,
159
 is reported lately. Another contribution to the description of eye 
development and also disease comes from studies with the homeobox gene Otx2 
160
 . 
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